Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

5931 - 5940 of 44782 results found

Strategies to reduce the risks of mRNA drug and vaccine toxicity

Date
Wednesday, January 24, 2024 - 4:00 AM
Description
mRNA formulated with lipid nanoparticles is a transformative technology that has enabled the rapid development and administration of billions of coronavirus disease 2019 (COVID-19) vaccine doses worldwide. However, avoiding unacceptable toxicity with

Additional booster doses in patients with chronic lymphocytic leukemia induce humoral and cellular immune responses to SARS-CoV-2 similar to natural infection regardless ongoing treatments: A study by ERIC, the European Research Initiative on CLL

Date
Wednesday, January 24, 2024 - 4:00 AM
Description
Profound immune dysregulation and impaired response to the SARS-CoV-2 vaccine put patients with chronic lymphocytic leukemia (CLL) at risk of severe COVID-19. We compared humoral memory and T-cell responses after booster dose vaccination or

Update on post infection of SARS-CoV-2 postural tachycardia syndrome

Date
Wednesday, January 24, 2024 - 4:00 AM
Description
新型冠状病毒感染对儿童健康的影响已成为突出的公共健康问题。新型冠状病毒感染后体位性心动过速综合征在儿童新型冠状病毒感染后遗症中较常见。本文针对儿童新型冠状病毒感染后体位性心动过速综合征的定义、流行病学、主要临床表现、诊断及初步治疗方案进行综述。.